ED
CWK icon

Exane Derivatives’s Cushman & Wakefield Ltd CWK Stock Holding History

Exane Derivatives’s Portfolio CWK Stock Details CWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$584K Sell
38,306
-26,848
-41% -$472K 0.34% 68
2022
Q1 		$1.34M Sell
65,154
-6,545
-9% -$139K 0.38% 61
2021
Q4 		$1.59M Buy
71,699
+49,524
+223% +$957K 0.39% 54
2021
Q3 		$413K Buy
+22,175
New +$398K 0.1% 219

Other funds holding CWK

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Exane Derivatives's CWK Position: Q2 2022 in Review

Exane Derivatives reduced its Cushman & Wakefield Ltd (CWK) stake by 41% in Q2 2022, selling an estimated $472K and leaving 38,306 shares worth $584K. The position accounts for 0.34% of the portfolio, ranked #68.

Exane Derivatives first reported a position in CWK in Q3 2021 and has held it in 4 quarters since. The position peaked at $1.59M in Q4 2021. 197 funds tracked by Wall St. Rank hold CWK as of Q2 2022.

  • Exane Derivatives held 38,306 shares of Cushman & Wakefield Ltd worth $584K as of Q2 2022.
  • Exane Derivatives sold 26,848 Cushman & Wakefield Ltd shares in Q2 2022, an estimated $472K.
  • Cushman & Wakefield Ltd made up 0.34% of Exane Derivatives's portfolio in Q2 2022, its #68 holding.
  • Exane Derivatives first reported a position in Cushman & Wakefield Ltd in Q3 2021 and has held it in 4 quarters since.
  • Exane Derivatives's Cushman & Wakefield Ltd position peaked at $1.59M in Q4 2021.
  • 197 funds tracked by Wall St. Rank held Cushman & Wakefield Ltd as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.